Trade

Astec LifeSciences share price

High risk
  • 48%Low risk
  • 48%Moderate risk
  • 48%Balanced risk
  • 48%High risk
  • 48%Extreme risk
  • 570.30(-4.17%)
    January 23, 2026 15:15:54 PM IST
    • NSE
    • BSE
  • Vol : 59.06 K (NSE + BSE)
    Last 20 day avg : 89.91 K

Astec LifeSciences is trading -4.17% lower at Rs 570.30 as compared to its last closing price. Astec LifeSciences has been trading in the price range of 595.25 & 569.90. Astec LifeSciences has given -15.77% in this year & -8.86% in the last 5 days. The company posted a net profit of -24.43 Crores in its last quarter.Listed peers of Astec LifeSciences include Coromandel International (-1.27%), Pidilite Industries (-0.22%), SRF (-0.95%).The Mutual Fund holding in Astec LifeSciences was at 3.02% in 31 Dec 2025. The MF holding has decreased from the last quarter. The FII holding in Astec LifeSciences was at 0.04% in 31 Dec 2025. The FII holding has increased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Jan 24, 2026, 12:20 AM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.92
    Medium volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    2.36
    Higher than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    5.00
    Lower than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    0.00
    Higher than historical values
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
569.90
Highest
595.25
52 week range
Lowest
577.60
Highest
1,030.98
Astec LifeSciences Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Coromandel International
Bearish
2,249.80-1.2766,338.9539.156.370.505.40
Pidilite Industries
Bearish
1,449.00-0.221,47,421.0870.1715.090.692.26
SRF
Bearish
2,708.10-0.9580,522.1973.187.270.2516.14
Asian Paints
Neutral
2,712.000.332,60,235.5268.0113.770.907.13
Solar Industries India
Bearish
12,654.55-1.951,14,245.9790.2625.760.089.52
Mutual Fund Ownership
View all
Tata Retirement Savings Progressive Fund Growth
NA
  • Amount Invested (Cr.) 11.69
  • % of AUM 0.56
Tata Retirement Savings Conservative Fund Growth
NA
  • Amount Invested (Cr.) 0.52
  • % of AUM 0.29
ICICI Prudential Commodities Fund Regular Growth
NA
  • Amount Invested (Cr.) 7.56
  • % of AUM 0.28
ICICI Prudential Retirement Fund Hybrid Aggressive Plan Regular Growth
NA
  • Amount Invested (Cr.) 0.71
  • % of AUM 0.08
Nippon India Small Cap Fund - Growth
4/5
  • Amount Invested (Cr.) 30.99
  • % of AUM 0.05
Astec LifeSciences Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-01-30Quarterly Results
2025-10-29Quarterly Results
2025-07-28Quarterly Results
2025-04-23Audited Results
2025-01-27Quarterly Results
About the company Astec LifeSciences
  • IndustryChemical Manufacturing
  • ISININE563J01010
  • BSE Code533138
  • NSE CodeASTEC
Astec LifeSciences Limited is an India-based company, which is engaged in the manufacturing of agrochemical active ingredients (technical), bulk, formulations and intermediate products. The Company undertakes contract development and manufacturing services for a diverse range of agrochemicals. The Company operates through a single segment, namely Agrochemicals. Its product categories include Fungicide, Growth Regulator, Intermediates, Insecticide, and Herbicide. Its products include Azimsulfuron, Halosulfuron, Flutriafol, Rimsulfuron, Transfluthrin, Prothiaconazole, Metalaxyl, Cyproconazole, and Tribenuron methyl. It has a sales mix of both exports and domestic sales. It exports to approximately 17 countries, including the United States and countries across Europe, West Asia, South-East Asia, Latin America and Africa. The Company has approximately nine manufacturing plants, which are located in Maharashtra.
  • Management Info
  • Mugdha KhareChief Financial Officer
  • Arijit MukherjeeChief Operating Officer
  • Tejashree PradhanCompliance Officer, Company Secretary
  • Burjis GodrejManaging Director, Executive Non-Independent Director
Astec LifeSciences Share Price FAQs

Astec LifeSciences is trading at 570.30 as on Fri Jan 23 2026 09:45:54. This is -4.17% lower as compared to its previous closing price of 595.10.

The market capitalization of Astec LifeSciences is 1274.25 Cr as on Fri Jan 23 2026 09:45:54.

The 52 wk high for Astec LifeSciences is 1030.98 whereas the 52 wk low is 577.60

Astec LifeSciences can be analyzed on the following key metrics -

  • TTM P/E:
  • Sector P/E: 26.75
  • Dividend Yield: 0.00%
  • D/E ratio: 0.89

Astec LifeSciences reported a net profit of -134.75 Cr in 2025.

The Mutual Fund Shareholding was 3.02% at the end of 31 Dec 2025.